Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
about
Interventions for treating sexual dysfunction in patients with chronic kidney diseaseInterventions for treating sexual dysfunction in patients with chronic kidney diseaseClinical use of alprostadil topical cream in patients with erectile dysfunction: a reviewThe treatment of erectile dysfunction in patients with neurogenic diseaseProphylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patientsAlprostadil cream in the treatment of erectile dysfunction: clinical evidence and experienceDrug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sampleNon-surgical management of erectile dysfunction.Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trialsUK management guidelines for erectile dysfunction.Future prospects in the treatment of erectile dysfunction: focus on avanafil.Pharmacotherapy of sexual dysfunctions : current status.Economic aspects of medical erectile dysfunction therapies.Interactions between drugs for erectile dysfunction and drugs for cardiovascular disease.Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year?New achievements and pharmacotherapeutic approaches to impotence in the elderly.Topical alprostadil cream for the treatment of erectile dysfunction.Erectile dysfunction: symptom or disease?The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications.Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunctionA review of outcomes of an intracavernosal injection therapy programme.Intraurethral alprostadil for erectile dysfunction: a review of the literature.Sildenafil: two decades of benefits or risks?Alprostadil for the treatment of impotence.Physical activity on endothelial and erectile dysfunction: a literature review.The Challenge of Erectile Dysfunction Management in the Young Man.Adulterated and Counterfeit Male Enhancement Nutraceuticals and Dietary Supplements Pose a Real Threat to the Management of Erectile Dysfunction: A Global Perspective.Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.SILDENAFIL-ORAL MEDICATION FOR ERECTILE DYSFUNCTION-A REVIEWAdvances in the treatment of organic erectile dysfunction.Management of erectile dysfunction by the geriatrician.The role of penile prosthetic surgery in the modern management of erectile dysfunction.A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction.Myocardial infarction associated with intra-cavernosal administration of alprostadil in a patient with spinal cord injury and paraplegia.Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate.Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus.Malaysian cultural differences in knowledge, attitudes and practices related to erectile dysfunction: focus group discussions.Evaluation of health-related quality of life in patients treated for erectile dysfunction with viagra (sildenafil citrate) using SF-36 score.The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
P2860
Q24235471-1E5F2670-D985-41E1-8C6E-B64A8052C4F6Q24240619-C1C00733-91C5-4EC5-A6E2-D0D331635973Q26740510-2AA53333-7D25-4737-8484-EDD1B161BD1CQ26767305-D37F89F7-F82B-4F41-96A9-BD538D068C2DQ27022921-77A12170-A609-4E3B-8439-5AA256261A39Q28071503-A5150A60-C1F5-4C50-A6CB-D52C175BB6B0Q33578216-67EB6121-920C-440D-A368-F4F9A5E7CFBAQ33863945-15B671C7-DDD0-442B-95AE-CD683FA85D7EQ33888333-BF817DCD-BE76-44EF-B4CF-107C27BBD606Q34007643-FFC01DE0-AA6B-47FE-8957-2F587B2F885EQ34029414-E7E24961-DC15-45DD-B640-A4E47927A5EEQ34183723-3C5E0049-6337-46B4-9EA8-9F85A8DF585FQ34544717-07CEE0C2-CED4-4E9D-A6B5-1A8D0A5E2B6FQ34679612-CA36C512-1252-4936-AA86-0D7F387E3845Q35236700-ABA91703-2DC9-42B9-8538-0C365864F69DQ35569842-99807A77-B75D-4F44-8970-DB302C1AFDB9Q35688181-BEA36F04-12E5-4A10-8CA9-DCAE48C0ED1DQ35724843-623E04EA-F7F0-42A3-9D8D-A448CD2F6CF1Q36196988-4983B919-2514-4D2F-8E8D-AB05970AD4A5Q36453092-C05CEE75-AF26-42FE-8129-AE177E18395AQ36868048-D7D46730-BFD5-4948-AED4-6826F7A515E8Q38008053-151D6B76-192D-4BAC-B226-DFA82ED6DD61Q38061465-CD0CF400-FA11-47A8-AAAD-50F9946F8A1FQ38113844-3988BB79-AEAD-4884-8EEF-6BCE95A82307Q38173873-FFDBACE5-0AE9-42B7-AB43-30F99F217EFCQ38217424-162E09EB-5FE3-4EC5-8071-B7B8281EDE44Q38631968-F6A5752A-2CB9-411C-8513-F2A2AC2CDC1FQ38749357-C6B7DC92-A633-454C-9D0B-374813DA4F4DQ38846845-44EB43EE-DDBC-44C2-9218-EB8368680CE6Q41156150-0326C2EE-1FE8-4FA6-B999-95B0579552F6Q41436330-E87B2A30-423E-4D70-8BEE-63DCF9408DA7Q41610937-531F8390-9C83-48DA-A9F0-F54184D99ACEQ41807682-80ADDCA3-E438-4D9D-9944-8525BA9E598AQ42284379-03AAE524-608A-436E-A431-7B6E3432A618Q42551887-5305B048-9F28-49BA-BAAF-3D7882C7E662Q42615396-87F8B353-0958-4DFA-9C47-F838FAF5B207Q42919969-527CCA78-CDFA-4689-9DD5-72C91FB9E675Q43442216-C0123AA3-DD0C-4140-9842-7F5B982DA870Q43853523-6C987405-4C84-45E0-A893-F2E7333B53D6Q43891388-4D80DC8D-67F6-4C28-888A-97F6AACD0C2A
P2860
Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@ast
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@en
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@nl
type
label
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@ast
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@en
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@nl
prefLabel
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@ast
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@en
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@nl
P1476
Efficacy and safety of intraca ...... . The Alprostadil Study Group.
@en
P2093
P304
P356
10.1056/NEJM199604043341401
P407
P577
1996-04-01T00:00:00Z